InSysBio to present its poster at Tau2022 Global Conference

events
Conference
February 17, 2022

February 17, 2022

InSysBio announces its participation in Tau2022 Global Conference. Tau2022 is held virtually on February 22-23, 2022. InSysBio team presents a poster within its frames, namely:

  • "Application of AD quantitative systems pharmacology model to investigation of therapeutic efficacy of extracellular tau depletion" by Tatiana Karelina

Tatiana comments on the poster, "In the poster we try to anticipate brain dynamics of pathological tau deposits during gosuranemab treatment and predict how early therapy should be started for highest efficacy".

 

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

 

September 2018
MoTuWeThFrSaSu
     
1
2
3
4
5
6
7
8
9
10
11
1. 11 Sep 2018 15:30 InSysBio launches Alzheimer’s Disease Modeling Consortium InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced the launch of Alzheimer’s Disease (AD) Modeling Consortium. The aim of the consortium is the support of drug development in AD by consolidation of efforts of teams from various pharmaceutical companies in framework of development and application of AD QSP platform.
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
1. 26 Sep 2018 15:36 InSysBio launches Immune Response Template online InSysBio, a pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, today announced the launch of Immune Response Template (IRT) online. IRT is a QSP platform of human immune system and a tool for development of custom QSP models related to immune response.
27
28
29
30
Upcoming Events
Tags
Latest News
29.10
InSysBio to announce its collaboration with BeOne Medicines
16.10
InSysBio to introduce a new data annotation service available in CYTOCON DB and fIVE DB
19.08
InSysBio to publish the new article "Revolutionizing drug discovery: Integrating artificial intelligence with quantitative systems pharmacology"
05.08
InSysBio to launch Immune Response Template Open for QSP modeling
25.06
InSysBio to announce extension of collaboration with discoveric bio alpha